APA (7th ed.) Citation

Ramachandra, N., Vegivinti, C. T. R., Sahu, S., Sanawar, R., Rivera-Peña, B., Aminov, S., . . . Yingling, J. M. (2025). Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS. Leukemia & Lymphoma, 66(5), 920. https://doi.org/10.1080/10428194.2024.2444479

Chicago Style (17th ed.) Citation

Ramachandra, Nandini, et al. "Transforming Growth Factor Beta Receptor Type I (TGF-βRI) Kinase Inhibitors IOA-359 and IOA-360 Stimulate Erythropoiesis in MDS." Leukemia & Lymphoma 66, no. 5 (2025): 920. https://doi.org/10.1080/10428194.2024.2444479.

MLA (9th ed.) Citation

Ramachandra, Nandini, et al. "Transforming Growth Factor Beta Receptor Type I (TGF-βRI) Kinase Inhibitors IOA-359 and IOA-360 Stimulate Erythropoiesis in MDS." Leukemia & Lymphoma, vol. 66, no. 5, 2025, p. 920, https://doi.org/10.1080/10428194.2024.2444479.